Skip to main content

Table 3 Pharmacotherapy after the event

From: Lifestyle behaviours in patients with established cardiovascular diseases: a European observational study

 Men
(n = 608)
Women
(n = 294)
p-value
Betablockers, n (%)368 (60.53%)155 (52.72%)0.026
ACEi/ARBs, n (%)450 (74.01%)216 (73.47%)0.862
Statins, n (%)544 (89.47%)241 (81.97%)0.002
Antiplatelet, n (%)530 (87.17%)236 (80.27%)0.007
Anticoagulants, n (%)58 (9.54%)53 (18.03%)< 0.001
  1. ACEi Angiotensin-converting-enzyme inhibitor, ARBs Angiotensin II receptor blockers